<DOC>
	<DOCNO>NCT01002326</DOCNO>
	<brief_summary>The purpose study develop test effectiveness Cognitive-Behavioral Therapy ( CBT ) child adolescent suffer Body Dysmorphic Disorder .</brief_summary>
	<brief_title>Cognitive-Behavioral Therapy Pediatric Body Dysmorphic Disorder</brief_title>
	<detailed_description>The main purpose trial develop investigate effect CBT protocol child adolescent BDD . It important investigate CBT population give disorder 's early onset poor trajectory leave untreated . In first phase trial , develop treatment manual , adapt adult manual use pediatric population . In second phase trial test effectiveness CBT treatment 12 pediatric BDD patient . We intend treat 12 child adolescent BDD . All patient receive CBT . We also examine treatment feasibility acceptability ( e.g. , retention reason treatment refusal dropout , expectancy , motivation ) , explore predictor outcome . Therapeutic progress broadly assess measure belief , behavior , mood , functioning , quality life , , treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Body Dysmorphic Disorders</mesh_term>
	<criteria>Diagnosis DSMIV BDD delusional variant , must present currently least 6 month prior study entry Total score least 24 12item BDDYBOCS , adolescent version , include score least 2 item 1 ( 13 hours/day preoccupation perceive defect ) Score least moderate Clinical Global Impressions Severity ( CGISeverity ) Score &lt; 60 Child Global Assessment Scale ( CGAS ) Ability communicate meaningfully investigator competent provide write assent ; parental informed consent adolescent assent must obtain Alcohol substance abuse dependence within past 3 month , bipolar disorder , psychosis , organic mental disorder , development disorder , body image concern account primarily eat disorder weight concern . If subject another comorbid diagnosis , BDD primary concern . Recent ( within past 6 month ) suicide attempt , suicidal ideation indicate KSADS score 4 high active warrant consideration hospitalization Need inpatient partial hospital treatment Current psychotherapy failure benefit ten session previous CBT treatment Participants receive psychotropic medication , must stable dose 2 month prior study baseline assessment maintain dosage throughout course study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>Body Dysmorphic Disorder</keyword>
	<keyword>BDD</keyword>
	<keyword>CBT</keyword>
	<keyword>Cognitive-Behavioral Therapy</keyword>
</DOC>